GB2050358A - Derivatives of phenylcyclohexane - Google Patents

Derivatives of phenylcyclohexane Download PDF

Info

Publication number
GB2050358A
GB2050358A GB8014622A GB8014622A GB2050358A GB 2050358 A GB2050358 A GB 2050358A GB 8014622 A GB8014622 A GB 8014622A GB 8014622 A GB8014622 A GB 8014622A GB 2050358 A GB2050358 A GB 2050358A
Authority
GB
United Kingdom
Prior art keywords
mls
alpha
trans
water
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB8014622A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Maggioni Farmaceutici SpA
Original Assignee
Maggioni Farmaceutici SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maggioni Farmaceutici SpA filed Critical Maggioni Farmaceutici SpA
Publication of GB2050358A publication Critical patent/GB2050358A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/36Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C201/00Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
    • C07C201/06Preparation of nitro compounds
    • C07C201/12Preparation of nitro compounds by reactions not involving the formation of nitro groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/004Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with organometalhalides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/562Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with nitrogen as the only hetero atom
    • C07C45/565Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with nitrogen as the only hetero atom by reaction with hexamethylene-tetramine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/527Unsaturated compounds containing keto groups bound to rings other than six-membered aromatic rings
    • C07C49/563Unsaturated compounds containing keto groups bound to rings other than six-membered aromatic rings containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Lubricants (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Antidepressants and central nervous system equilibrating agents having the general formula: <IMAGE> wherein A and B are different and can be phenyl or cyclohexyl, X is an aliphatic residue and Y and Y' are hydrogen or an alkyl radical possibly bound to a cyano group or can be replaced by a single radical connected to the N atom by a double bond.

Description

SPECIFICATION Derivatives of phenylcyclohexane This invention relatives to a series of amine derivatives carrying the phenylcyclohexane radical, which can display interesting pharmacological properties e.g. as analgesics, antidepressants, and central nervous system equilibrating agents.
The general formula of these compounds is the following:
wherein A and B are different from one another and are selected from phenyl and cyclohexyl; Xis an aliphatic radical containing from 1 to 5 carbon atoms; and Y and Y' are the same or different and are selected from hydrogen and straight and branched alkyl radicals containing from 1 to 5 carbon atoms and possibly a -CN group, or are replaced by a single radical connected to the nitrogen atom by a double bond. X can be straight or branched chain or comprise a cycloaliphatic ring.
Thus, two sub-series of compounds can be obtained, one with A=phenyl and B=cyclohexyl, and vice versa: when B is cyclohexyl, the compounds can take either the "cis" or the "trans" configuration.
Compounds of this invention have been tested for the inhibition of reserpine-induced hypothermia in mice, according to the procedure of Askew, B.M., Life Sci., 2,725(1963), and have proven active.
A representative compound of the series, alpha, alpha-dimethyl-(4-phenylcyclohexyl)-methylamine, at a dosage of 40 micromol/kg b.w. has caused a temperature increase of 15.5"C, and at 160 micromol/kg b.w. the increase was 18.4"C. Another compound, alpha-methyl-(4-phenylcyclohexyl)-methylamine, has given, at the same dosages indicated above, temperature increases of 14.6"C and 23.6"C, respectively. A third compound, alpha-methyl-N-2-cyanoethyl-(4-phenylcyclohexyl )-methylamine, has caused buddy temperature increases of 10.6on and by 19.2"C, respectively.
The compounds of this invention may also be effective in inhibiting the eyelid ptosis induced by reserpine in mice according to the procedure of Wilson, S.P., and Tislo, R., Proc. Soc. Exp. Biol. Med., 109,847 (1962).
The compounds in question can increase the hyperthermia caused by 5-hydroxytryptophan in rats previously treated by the procedure of Jori, A. and Garattini, S., J. Pharm.Pharmacol., 17,480 (1965), and can increase the behavioral modifications induced in mice by 5-hydroxytryptophan according to the disclosure of Lippmann, W., and Prigsley, T.A., Arch. Int. Pha rmacodyn., 227,324(1977).
The three substances which have been more closely investigated did not display any influence on the spontaneous motility of mice, as tested by the procedure disclosed by Cantarelli, G., Carissimi, M., Cattaneo, A., D'Ambrosio, R., Grumelli, E., Milla E., Panelli, M., and Ravenna, F., II Farmaco, Ed. Sc., 24, 123(1969), nor do they inhibit monoaminooxidase when tested according to the procedure described by Tedeschi, D. H. and Tedeschi, R.E., Fellows E.J., Proc.Soc.Exp. Biol. Med., 103,608 (1960).
The pharmacological properties set forth above permit the characteristics of antidepressive drugs in humans to be attributed to the compounds of the present invention.
A number of procedures have been followed for preparing the antidepressive drugs of the present invention, e.g.
a) Treatment of an aromatic halomethyl derivative with hexamethylene tetramine; b) Reduction of a ketoxime; c) Reduction of a nitroderivative; d) Condensation of acrylonitrile with a primary amine; e) Reaction of dimethylformamide with a ketone; f) Reaction of formic acid and formaldehyde with a primary amine; g) Ritter's reaction on a tertiary alcohol; h) Condensation of an aliphatic aldehyde with a primary amine, followed by catalytic hydrogenation of the double bond.
The first of these methods has permitted preparation of the methylamine derivatives in particular, whereas the second and the third methods have been used to prepare both the ethylamine derivatives and those having a longer carbon atom chain.
The thus prepared primary amines have been condensed with an appropriate carbonyl derivative and the product thus obtained has been reduced in order to prepare the N-substituted derivatives. Formaldehyde has been used for preparing the N-methyl derivative.
Afew examples are given to illustrate the invention without limiting same.
EXAMPLE 1 4-cyclohexylbenzylamine . - To a solution of 52 grams (g) of hexamethylenetetramine in one litre of chloroform, maintained at 50"C, there was added slowly, over 3 hours, a solution of 4-cyclohexyl-alpha-chlorotoluene in 2 litres of chloroform. After a 24-hour stirring at 50"C, the mixture was evaporated to a volume of about 1 litre and poured into 3 litres of ethyl ether and the resulting solid was filtered off, washed with ether and dried.
Into a solution of 45 g of the adduct in 1.6 litres of ethanol there was dripped 900 mls of conc. HCI and the mixture was refluxed with stirring for 24 hrs. and then evaporated to dryness under reduced pressure; the residue was taken up with water, treated with soda to an alkaline pH and extracted with ethyl acetate. The extracts were combined, washed with water and dried over sodium sulfate and evaporated, to give an oil which was distilled, b.p. 1 18'C - 119"C under 0.9 millimetres of mercury (mmHg).
EXAMPLE 2 Al pha-methyl-4-cyclohexyl benzylamine . a) 4-cyclohexylacetophenoneoxime . - A solution of 41 g (0.2 mol) of 4-cyclohexylacetophenone in 500 mls of Abs. EtOH was admixed with a solution of 21 g of hydroxylamine hydrochloride in 100 mls of water had dripped continuously thereinto 32 g of NaOH in 100 mis of water. The mixture was subsequently brought to the boil for 5 hrs., allowed to cool and poured into 3 litres of water. Upon cooling, the precipitate was collected on a filter, washed with water and recrystallized from 50% EtOH. Yield : 37.3 g (85% of theory) - M.p. 1 18"C.
b) alpha-methyl-4-cyclohexylbenzylamine.- A solution of 7.5 g of 4-cyclohexylacetophenoneoxime in 100 mis of abs. EtOH was treated with 750 milligrams (mg) of 10% Pd on activated charcoal and hydrogenated in a Parr apparatus at room temperature and under a pressure of 4 atmospheres. After removal of the catalyst and evaporation of the solvent, an oil was left, which was distilled. B.p. 122"C-123"C under 0.7 mm Hg.
EXAMPLE 3 Trans-alpha-methyl-4-phenylcyclohexylmethylamine . - a) Trans-1-acetyl-4-phenylcyclohexane.- Into a suspension of 8 g. of lithium in small pieces in 300 mls ethyl ether (anhydrous), under a nitrogen blanket, there was slowly dripped a solution of 82.4 g of methyl iodide in 300 mls of anh.ethyl ether. On completion of the addition, the mixture was stirred for one hour at room temperature and quickly filtered on glass wool under a nitrogen blanket and introduced over about 3 hrs. into a solution of 31 g of trans-4-phenylcyclohexanecarbonic acid in 2.2 litres of anh. ethyl ether. The suspension thus obtained was brought to the boil with stirring for 8 hrs., then allowed to cool and poured into water.The organic layer was separated and the water layer washed with ether. The combined ethereal extracts were washed with a 5% solution of sodium bicarbonate and then with water, dried on sodium sulfate and then evaporated. The residual oil was distilled at 1340C under 0.7 mmHg. Yield 28.5 g (93% of theory).
b) Trans- 1-acetyl-4-phenylcyclohexaneoxime. The procedure is akin to that described in EXAMPLE 2, item a). The product melts at 184 C-186 C (from 95% EtOH). Yield is 76% of theory.
c) Trans-alpha-methyl-4-pnenylcyclohexylmethylamine. - To a suspension of 11.2 g of lithium and aluminum hydride in 500 mls of anh.ether there were slowly added 16 g of trans-1-acetyl-4-phenylcyclohexaneoxime dissolved in 500 mis of tetrahydrofuran and 400 mls ethyl ether and the mixture was brought to the boil with stirring for 11 hrs. Upon cooling, there were cautiously added 12 mls of water, 12 mls of 15% NaOH soln. and eventually 35 additional mls of water, and the suspension was allowed to stand with stirring for 30 mins. at room temperature.The resulting solid was filtered off, washed thoroughly with ethyl acetate and the filtrates were combined, dried over sodium sulfate, and evaporated, and the oily residue distilled. B.p. 125"C-128"C under 0.8 mmHg.
EXAMPLE 4 Trans-alpha-methyl-rN-2-cyanoethyl-4-phenylcycloheXylJ-methylamine . 46 g of trans-alpha-methyl-(4-penylcyclohexyl)-methylamine base was brought to the boil with 60 mls of acrylonitrile for 6 hrs. The solution was evaporated under vacuum and the residue dissolved in ethyl ether, converted into its hydrochloride and recrystallized from 95% EtOH. Yield : 3.6 g (60% of theory). M.p. 231"C 233"C.
EXAMPLE 5 Trans-alpha-methyl-(N-methyl-4-phenylcyclohexyl)-methylamine . - A mixture of 18.6 g of trans-1 -acetyl-4-phenylcyclohexane, 23.6 g of N-methylformamide and 15 mls of 99% formic acid was heated with stirring to 1 950C for 24 hrs. Upon cooling, there were added 100 mls of conc. HCI and the resultant mixture was refluxed again for 12 hours, diluted with 200 mis of water and extracted with ethyl ether. The watery liquors, when treated with soda and extracted with ether, gave an oily base which was converted into its hydrochloride, then purified with EtOH-ethyl ether. Yield 19.780 (85% of theory). M.p. 192"C-194"C.
EXAMPLE 6 Trans-alpha-methyl-6N,N-dimethyl-4-phenylcycloheXylJ-methylamine . - A mixture of 13.8 g of trans-alpha-methyl-4-phenylcyclohexylmethylamine hydrochloride, 43.05 g of 99% formic acid and 78.5 mls of a 39% solution of formaldehyde was heated with stirring to 1 OO"C for 10 hrs.
Upon cooling the mixture was diluted with water, made alkaline with conc. NaOH and extracted with ethyl acetate. The residue obtained on evaporation of the organic phase was dissolved in ethyl ether and converted into its hydrochloride, then recrystallized from acetone. Yield : 9.7 g (63% of theory) - M.p. 176"C 178"C.
EXAMPLE 7 Trans-alpha, alpha-dimethyl-(4-phenylcyclohexyl)-methylamine . - a) Trans-r4-phenylcyclohexylJ-alpha,alpha-dimethyl-methanol.- To a suspension of 8 g of lithium in 180 mls anh.ethyl ether there was slowly added under a nitrogen stream 82.4 g of methyl iodide in 250 mls ethyl ether. After 30 mins. heating at room temperature there was dripped thereinto 32.6 g of trans-4-phenyl-cyclohexane-carbonic acid chloride in 1.3 litres of anh.ethyl ether.
Heating was continued with stirring, still under a nitrogen stream, for 9 hrs. and the mixture, upon cooling, was quickly filtered under a nitrogen stream on glass wool to remove the unreacted Li, and slowly diluted with 1.3 litres of water, the organic phase being separated. Upon cooling and evaporation under vacuum, a solid was obtained which could be recrystallized from 500 mls of petroleum ether at -25"C. Yield : 63% of theory - M.p. 68"C - 69"C - B.p. 151"C under 1 mmHg.
b) Trans-alpha, alpha-dimethyl-(4-phenylcyclohexyl)-methylamine. To 4.77 g of potassium cyanide there was added a solution of 13.08 g of trans-(4-phenylcyclohexyl)alpha,alpha-dimethylmethanol in 18 mls of acetic acid, whereafter, without exceeding 50"C, there was added dropwise with stirring a cold solution of 15 mls of conc. sulfuric acid and 11 mls of glacial acetic acid. After 6-hour stirring at 50"C, the contents of the flask were poured into water and the resulting solid was collected on a filter, dried and washed with ether. The ultimate purification was carried out by recrystallization from water and washing with methanol-ethyl ether. Yield : 8.9 g (59% of theory) - M.p. 306"C-307"C.
EXAMPLE 8 Trans-alpha-methyl-(n-propyl-4-phenylcyclohexyl )-methylamine . a) Trans-N-propylidene-alpha-methyl-4-phen ylcyclohexylmethylamine . A solution of 7.2 g oftrans-alpha-methyl-(4-phenylcyclohexyl)-methylamine in 500 mls anh.benzene was treated with 3.08 g of propionaldehyde in 10 mls benzene, refluxed for 20 hrs., and evaporated. The residue, as obtained, was used as such for the subsequent reduction, without any purification step.
b) Trans-alpha-methyl-{N-propyl-4-phenylcyclohexylJ-methylamine.- A solution of 9.1 g oftrans-alpha-methyl-(N-propylidene-4-phenylcyclohexyl)-methylamine in 100 mix of ethyl acetate, to which there had been added 0.8 g of PtO2, was hydrogenated at room temperature and under a pressure of 3.5 atmospheres. Upon removal of the catalyst by filtration, the solution was evaporated under vacuum, the residue was dissolved in ethyl ether, filtered on activated charcoal and converted to its hydrochloride: the latter was collected on a filter and recrystallized from isopropanol. Yield : 2.8 g (27% of theory) - M.p. 215'C - 217 C.
EXAMPLE 9 Trans-alpha-butyl-(4-phenylcyclohexyl)-methylamine.- a) Trans- l-(4-phenylcyclohexyl)-pentanone . Under a nitrogen blanket, 21.92 g of butyl bromide in 160 mls of ethyl ether was dripped into a mixture of 4.32 g of magnesium shavings in 160 mls ethyl ether. After 30 mins. of heating, there was added 16.32 g of trans-4-phenyl-cyclohexanecarbonitrile in 200 mis of anh. benzene. The internal temperature was brought to 60 C by distilling off the volatile fraction, whereafterthe mixture was brought to the boil for 3 hrs.Upon cooling, there were added 40 mis of glacial acetic acid and 20 mls of water : the mixture was boiled for 3 additional hours. The mixture was then poured into iced water and extracted with benzene. Upon drying and evaporation under vaccum, an oily product was isolated. Yield 16 g (75% of theory) - B.p. 149C under 0.3 mmHg. The 2,4-dinitrophenylhydrazone melts at 136 C - 137"C.
b) Trans- l-(4-phenylcyclohexyl)-pentanoneoxime. - The procedure is akin to that described in EX. 2 item a).
The product melts at 96"C-98"C. Yield : 6.25 g (75% of theory).
c) Trans-alpha-butyl-4-phenylcyclohexylmethylamine . - To a mixture of 3.3 g of lithium and aluminum hydride in 150 mls of anh. ethyl ether, there were added dropwise 5.7 g ofthetrans-1-(4-phenylcyclohexyl)-pentanoneoxime in 150 mls of tetrahydrofuran and 120 mls ethyl ether. Subsequently, the whole mixture was refluxed with stirring for 20 hrs. Upon cooling, the excess hydride was destroyed by the addition of 5 mls of water, 5 mls of 5% NaOH and 15 mls of water. Upon dilution with ethyl acetate, the mixture was filtered and the lithium and aluminum hydroxides were washed away with additional solvent and, upon drying on sodium sulfate, the organic phase was evaporated under vacuum.The residue was dissolved in ethyl ether, filtered with activated charcoal and converted to its corresponding hydrochloride. Upon cooling, the precipitate was collected on a filter, washed with ether, dried over phosphorus pentoxide and recrystallized from acetone. Yield : 3.53 g (57% of theory) - M.p. 187"C 189"C.
EXAMPLE 10 Trans-alpha-cycloprnpyl-4-phenyl-cyclohexanemethylamine . - a) Trans-(4-phen ylcyclohexyl)-cyclopropylketone. - Under a nitrogen blanket, to 6.48 g of Mg slurried in 200 mls of ethyl ether, there was added 57.36 g of 4-phenylcyclohexyl bromide in 250 mls of ethyl ether. Afterrefluxing for 2 hrs there was added dropwise 8.88 g of cyclopropyl cyanide in 150 mls of ethyl ether, whereafter the solution was brought to the boil for 8 hours. Subsequently, there were added 50 mls of acetic acid, 20 mls of conc. HCI and 50 mls of water and, still under a nitrogen blanket, the mixture was refluxed for 3 hrs.Upon cooling, there were added water and ice and extraction with ethyl acetate was carried out. The extracts were combined and evaporated and the residual oil distilled. It has a b.p. of 148"C - 152"C under 0.1 mmHg.
By purification by chromatography on a column filled with silica gel (eluant hexane and ethyl acetate (v/v 9:11)) there was obtained 5 g of a pure product having a m.p. of 82"C, to which the "trans" structure has been attributed.
b) Trans-(4-phenylcyclohexyl)-cyclopropylketoneoxime, - The procedure is akin to that described in EXAMPLE 2, item a).
The product melts at 189eC - 1 71"C - Yield : 2.4 g (42% oftheory).
c) Trans-alpha-cyclopropyl-4-phenylcyclohexanemethylamine . To a solution of 0.55 g of LiAIH4 in 25 mls anh. ethyl ether there were added dropwise 0.89 g of trans-(4-phenylcyclohexyl)-cyclopropylketoneoxime dissolved in 25 mls of tetrahydrofuran and 25 mls ether and the mixture was brought to the boil for 20 hrs with stirring. Upon cooling there were added, in the order given, 1 ml of water, 1 ml of 5%-NaOH and 3 mls of water: stirring was applied for a short time, and the Al and Li hydroxide were filtered off and washed with ether. The organic phase was evaporated and the oily residue, converted to its hydrochloride, was recrystallized from isopropanol. Yield : 0.37 g (38% of theory) M.p.265 C- 267 C.
EXAMPLE 11 1 -(4-cyclohexyl phenyl)-2-aminopropane . a) 4-cyclohexylbenzaldehyde. A mixture of 350 mis of glacial acetic acid, 350 mls of water, 172 g of 4-cyclohexyl-alpha-chlorotoluene and 231 g of hexamethylenetetramine was refluxed with stirring for 2 hrs. Upon cooling, there were added 280 mls of dil. HCI and the mixture was brought to the boil for 15 additional minutes, whereafter it was cooled, diluted with water and repeatedly extracted with ethyl ether.
The combined extracts were washed with water, 10% sodium bicarbonate and with water again, dried and evaporated under vacuum. The oily residue was distilled at 122 C-125 C under 0.5 mmHg. Yield:113 g (72% of theory) b) l-(4)cyclohexylphenylj-2-nitropropene . - A mixture of 50 g of 4-cyclohexylbenzaldehyde, 24 g of freshly distilled nitroethane and 16.2 g of ammonium acetate in 200 mls of glacial acetic acid was brought to the boil with stirring for 5 hrs., and, upon cooling, poured into cold water and allowed to cool. The water layer was decanted and the oil lying on the bottom extracted with ethyl acetate and washed with water. Upon drying on sodium sulfate and evaporation of the solvent, the oily residue was distilled.After a head fraction which essentially contained the unreacted aldehyde, there distilled between 160"C and 180;C a fraction which was very rich in the expected product. It was percolated on a Nylon column filled with silica gel (2-metre high, 5 cm dia.) using benzene as the extractant. As the solution reached the column bottom, the yellow-colored sections were cut away and extracted with acetone and 25 g of product (39% of theory) were obtained, having a b.p. of 161"C-1 68"C under 0.5 mmHg.
c) l-(4-cyclohexylphenyl)-2-aminopropane. - To a suspension of 9.3 g of LiAIH4 in 500 mls of anh. ethyl ether there was slowly added dropwise 10 g of 1 -(4-cyclohexylphenyl)-1 -nitropropene in 150 mis ethyl ether (an hydrous) and the mixture was refluxed with stirring for 7 hrs. Upon cooling, there were slowly added, in the order given, 11 mls of water, 11 mls of 15% NaOH and lastly 35 mls of water. After a 30-min. stirring at room temp., the precipitate was collected on a filter and washed with ethyl acetate and the combined filtrates were dehydrated (sodium sulfate). By evaporation, an oil was obtained, which distilled at 118"C-123"C under 0.6 mmHg.It was converted to its hydrochloride which has a m.p. 2540C.
EXAMPLE 12 Trans-1 -(4-phenylcyclohexyl)-2-aminopropane . a) Trans- l-(4-phen ylcyclohexyl)-2-nitropropene . A mixture of 25 g of trans-4-phenylcyclohexanealdehyde, 11 g of freshly distilled nitroethane and 8.3 g of ammonium acetate in 75 mls of glacial acetic acid was refluxed under a nitrogen blanket for 22 hrs, then poured in water; the oily residue lying on the bottom was extracted with ether and the ethereal solution washed with sodium carbonate, then with water, dried and evaporated. The oily residue was purified by recrystallizing it from isopropanol.
Yield 11.6 g (38% of theory) of a product which is virtually pure by thin-layer chromatography.
By distillation (b.p. 170"C-172"C under 0.9 mmHg) a pure product was obtained, which had a m.p. of 102"C-1 04"C.
b) Trans- l-(4-phen ylcyclohexyl)-2-aminopropane. - The procedure is akin to that described in EXAMPLE 11, item c).
The trans-1 -(4-phenylcyclohexyl -2-aminopropane melts at 261 C-263 C (when recrystallized from isopro panol).

Claims (8)

1. A compound of the formula:
wherein one of A and B is phenyl and the other is cyclohexyl, Xis an aliphatic radical containing from 1 to 5 carbon atoms, and Y and Y' are the same or different and are selected from hydrogen and alkyl radicals containing from 1 to 5 carbon atoms and possibly a -CN group, or are replaced by a single radical connected to the nitrogen atom by a double bond.
2. Trans-alpha-methyl-4-phenylcyclohexylmethylamine.
3. Cis-alpha-methyl-4-phenylcyclohexylmethylamine.
4. Trans-alpha,alpha-dimethyl-4-phenylcyclohexylmethylamine.
5. Trans-alpha-methyl-N-(2-cyanoethyl )-4-phenylcyclohexylmethylamine.
6. A compound according to claim 1 substantially as hereinbefore described in any one of the Examples.
7. A method of preparing a compound according to claim 1, the method being substantially as hereinbefore described.
8. A method of preparing a compound according to claim 1, the method being substantially as hereinbefore described in any one of the Examples.
GB8014622A 1979-05-09 1980-05-02 Derivatives of phenylcyclohexane Withdrawn GB2050358A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT22483/79A IT1113391B (en) 1979-05-09 1979-05-09 PHENYLCYCLOHEXANIC DERIVATIVES WITH ANTI-PRESSURE ACTIVITY

Publications (1)

Publication Number Publication Date
GB2050358A true GB2050358A (en) 1981-01-07

Family

ID=11196874

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8014622A Withdrawn GB2050358A (en) 1979-05-09 1980-05-02 Derivatives of phenylcyclohexane

Country Status (5)

Country Link
JP (1) JPS568351A (en)
DE (1) DE3017815A1 (en)
FR (1) FR2455889A1 (en)
GB (1) GB2050358A (en)
IT (1) IT1113391B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2192881A (en) * 1986-07-16 1988-01-27 Ici Plc Tertiary amine compounds
US6235791B1 (en) 1996-07-29 2001-05-22 Sanofi-Synthelabo Use of amines to produce drugs for preventing tumor cell proliferation

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2641276B1 (en) * 1988-12-30 1991-07-12 Sanofi Sa BENZENE DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE477026A (en) *
NL125843C (en) * 1961-03-06
GB1475314A (en) * 1973-11-02 1977-06-01 Cm Ind Phenyl-propylamine derivatives
JPS5223051A (en) * 1975-08-09 1977-02-21 Takeda Chem Ind Ltd Preparation of cyclohexane derivatives

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2192881A (en) * 1986-07-16 1988-01-27 Ici Plc Tertiary amine compounds
US6235791B1 (en) 1996-07-29 2001-05-22 Sanofi-Synthelabo Use of amines to produce drugs for preventing tumor cell proliferation

Also Published As

Publication number Publication date
IT7922483A0 (en) 1979-05-09
DE3017815A1 (en) 1980-11-27
FR2455889A1 (en) 1980-12-05
JPS568351A (en) 1981-01-28
IT1113391B (en) 1986-01-20

Similar Documents

Publication Publication Date Title
US4024274A (en) Benzylamine derivatives and process for preparing them
Lavagnino et al. Conidine—Synthesis, Polymerization and Derivatives
DE2136571C2 (en) Phenyl-2-pyrrolidinones, process for their preparation and pharmaceuticals containing them
US3592824A (en) 3-substituted amino-1,2,3,4-tetrahydrocarbazoles
CRONYN AZABICYCLOALKANES. 2-AZABICYCLO [3· 3· 1] NONANE1, 2
EP0028381B1 (en) Azepinoindoles, process for their production and pharmaceutical compositions containing them
EP0009800B1 (en) 4-phenyl-1,3-benzodiazepines, method for their preparation, pharmaceutical compositions containing them, and the compounds for use as medicaments
CA1340479C (en) Indane derivatives, process for preparing the same, new intermediates produced, use thereof as therapeutic agents and pharmaceutical compositions containing them
Wawzonek et al. The Formation of 4-chlorodibutylamine from N-chlorodibutylamine1
GB2120662A (en) New azepinoindoles, their production and pharmaceutical compositions containing them
IE47518B1 (en) Indolo (2,3-a) quinolizidines,preparation and therapeutic use
CZ285696B6 (en) Hexahydroazepine derivative, process of its preparation, pharmaceutical composition containing thereof and use of the derivative for preparing such pharmaceutical composition
GB2050358A (en) Derivatives of phenylcyclohexane
Boekelheide et al. Syntheses of 14, 15, 16, 17-Tetrahydroerythrinane1, 2
JPS5980668A (en) Optically active derivative of n-arylated oxazolidin-2-one, manufacture and drug
Leonard et al. Rearrangement of α-Aminoketones During Clemmensen Reduction. XI. The Reduction of Atom-bridged Bicyclic α-Aminoketones1, 2
US6512114B1 (en) Process for the preparation of Midazolam
US3159677A (en) Fluorenamines and process for preparation thereof
CA1164868A (en) Benzo [4,5]pyrano[2,3c]pyrroles, processes for their preparation and pharmaceutical preparations containing same
JPH0154341B2 (en)
Southwick et al. 1-Carbamoyl-and 1-aminomethyl-1, 4-dihydropyrrolo [3, 4-b] indole derivatives. Indole formation by fragmentation of strain-barrier stabilized 2-aminoindoline derivatives
Viallon et al. Thermal and acid-catalysed sigmatropic rearrangements of allylamino-methoxy-1, 2-benzoquinones
US2970159A (en) Hydrazine derivatives
DK169549B1 (en) Pyrimidoindoles, their preparation and pharmaceutical composition containing them
AT208872B (en) Process for the preparation of new 1,4-diazacycloheptanes

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)